Cargando…

O9.1. CANNABIS AND OTHER SUBSTANCE USE DISORDERS PREDICT CONVERSION FROM SCHIZOTYPAL DISORDER TO SCHIZOPHRENIA

BACKGROUND: Schizotypal disorder has been linked to conversion to schizophrenia, with a quarter to half of patients converting over a course of two to five years. Substance use disorders are common in patients with schizotypal disorder, and cannabis has been shown to be a risk factor for developing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hjorthoj, Carsten, Albert, Nikolai, Nordentoft, Merete
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888243/ http://dx.doi.org/10.1093/schbul/sby015.245

Ejemplares similares

M94. NO EVIDENCE OF ASSOCIATIONS BETWEEN GENETIC LIABILITY FOR SCHIZOPHRENIA RISK OF CANNABIS USE DISORDER
por: Hjorthøj, Carsten, et al.
Publicado: (2020)

T83. SUBSTANCE-INDUCED PSYCHOSIS LINKED TO BOTH INFECTIONS AND SCHIZOPHRENIA
por: Hjorthøj, Carsten, et al.
Publicado: (2020)

T214. ANTIPSYCHOTIC TREATMENT PATTERNS AND EFFECTS DURING THE EARLY YEARS AMONG 316 NEWLY DIAGNOSED PATIENTS WITH SCHIZOPHRENIA FROM THE OPUS TRIAL
por: Albert, Nikolai, et al.
Publicado: (2020)

The effect of duration of untreated psychosis and treatment delay on the outcomes of prolonged early intervention in psychotic disorders
por: Albert, Nikolai, et al.
Publicado: (2017)

S102. CANNABIS MAY PROTECT AGAINST CERTAIN DISORDERS OF THE DIGESTIVE ORGANS IN PATIENTS WITH SCHIZOPHRENIA BUT NOT IN HEALTHY CONTROLS
por: Olesen, Julie Aamand, et al.
Publicado: (2018)

TAILOR – tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial
por: Stürup, Anne Emilie, et al.
Publicado: (2017)

S121. OPUS 20, 20 YEAR FOLLOW-UP ON THE OPUS TRIAL
por: Starzer, Marie, et al.
Publicado: (2020)

O7.7. COGNITIVE FUNCTIONING FOLLOWING DISCONTINUATION OF ANTIPSYCHOTIC MEDICATION: A SUB-GROUP ANALYSIS FROM THE OPUS II TRIAL
por: Albert, Nikolai, et al.
Publicado: (2018)

T42. WHEN SHOULD EARLY INTERVENTION START, AND FOR HOW LONG SHOULD IT LAST?
por: Albert, Nikolai, et al.
Publicado: (2018)

T126. PSYCHIATRIC PREDICTORS FOR BECOMING HOMELESS AND EXITING HOMELESSNESS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Nilsson, Sandra, et al.
Publicado: (2020)

O8.6. RISK OF HOMELESSNESS AFTER DISCHARGE FROM PSYCHIATRIC WARDS
por: Nilsson, Sandra, et al.
Publicado: (2020)

S9. NEUROIMAGING AND NEUROPHYSIOLOGY BIOMARKERS OF SCHIZOTYPAL PERSONALITY DISORDER: A SYSTEMATIC REVIEW
por: Attademo, Luigi, et al.
Publicado: (2020)

Categorical-dimensional approach to diagnostic of schizotypal disorder
por: Kotsiubinskii, A., et al.
Publicado: (2021)

S91. CLINICAL CHARACTERISTICS OF FORMAL THOUGHT DISORDER IN SCHIZOPHRENIA
por: Choi, Joonho, et al.
Publicado: (2018)

T54. TAILOR – TAPERED DISCONTINUATION VERSUS MAINTENANCE THERAPY OF ANTIPSYCHOTIC MEDICATION IN PATIENTS WITH NEWLY DIAGNOSED SCHIZOPHRENIA SPECTRUM DISORDERS IN REMISSION OF PSYCHOTIC SYMPTOMS
por: Dolmer, Signe, et al.
Publicado: (2018)

Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR
por: Stürup, Anne Emilie, et al.
Publicado: (2022)

S119. MULTICULTURAL IDENTITY INTEGRATION AND SCHIZOTYPAL PERSONALITY DISORDER
por: Lopez, Daisy, et al.
Publicado: (2018)

Pathogenic beliefs among patients with schizotypal personality disorder
por: Pattamanusorn, Nantida, et al.
Publicado: (2020)

Treatment of schizotypal disorder: a protocol for a systematic review of the evidence and recommendations for clinical practice
por: Gundersen, Kristina Ballestad, et al.
Publicado: (2023)

Collaborative care for panic disorder, generalised anxiety disorder and social phobia in general practice: study protocol for three cluster-randomised, superiority trials
por: Curth, Nadja Kehler, et al.
Publicado: (2017)

A Qualitative Study on the Implementation of Flexible Assertive Community Treatment – an Integrated Community-based Treatment Model for Patients with Severe Mental Illness
por: Nielsen, Camilla Munch, et al.
Publicado: (2021)

Self-Disorders in Asperger Syndrome Compared to Schizotypal Disorder: A Clinical Study
por: Nilsson, Maria, et al.
Publicado: (2020)

The psychopathological trajectories to delusion in Schizophrenia: the affective and schizotypal pathways
por: Borrelli, D., et al.
Publicado: (2022)

Design paper: The CapOpus trial: A randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis
por: Hjorthøj, Carsten, et al.
Publicado: (2008)

O12.7. RISK OF PSYCHOSIS IN OFFSPRING OF PARENTS WITH A HISTORY OF HOMELESSNESS DURING CHILDHOOD AND ADOLESCENCE: A NATIONWIDE, REGISTER-BASED, COHORT STUDY
por: Nilsson, Sandra Feodor, et al.
Publicado: (2018)

Associations between Schizotypal Facets and Symptoms of Disordered Eating in Women
por: Swami, Viren, et al.
Publicado: (2022)

The Performance of Visual Perceptual Tasks in Patients with Schizotypal Personality Disorder
por: Chepeliuk, Anastasia A., et al.
Publicado: (2021)

Schizotypal Disorder With Borderline Personality Traits: A Case Report
por: Reddy, Rakesh Byra, et al.
Publicado: (2023)

A Smartphone App to Promote Patient Activation and Support Shared Decision-making in People With a Diagnosis of Schizophrenia in Outpatient Treatment Settings (Momentum Trial): Randomized Controlled Assessor-Blinded Trial
por: Vitger, Tobias, et al.
Publicado: (2022)

The Risk of Schizophrenia and Child Psychiatric Disorders in Offspring of Mothers with Lung Cancer and Other Types of Cancer: A Danish Nationwide Register Study
por: Benros, Michael Eriksen, et al.
Publicado: (2013)

Collaborative care vs consultation liaison for depression and anxiety disorders in general practice: study protocol for two randomized controlled trials (the Danish Collabri Flex trials)
por: Curth, Nadja Kehler, et al.
Publicado: (2019)

Exercise for patients with major depression: a systematic review with meta-analysis and trial sequential analysis
por: Krogh, Jesper, et al.
Publicado: (2017)

Cognitive Processes and Resting-State Functional Neuroimaging Findings in High Schizotypal Individuals and Schizotypal Personality Disorder Patients: A Systematic Review
por: Zouraraki, Chrysoula, et al.
Publicado: (2023)

Psychotic and schizotypal symptoms in non-psychotic patients with obsessive-compulsive disorder
por: Solem, Stian, et al.
Publicado: (2015)

Computerized Adaptive Testing for Schizotypal Personality Disorder: Detecting Individuals at Risk
por: Li, Yaling, et al.
Publicado: (2021)

Integrating vocational rehabilitation and mental healthcare to improve the return-to-work process for people on sick leave with stress-related disorders: results from a randomized trial
por: Hoff, Andreas, et al.
Publicado: (2022)

ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine Framework
por: Ghitza, Udi E.
Publicado: (2014)

Cannabis and Other Substance Misuse: Implications and Regulations
por: Khairinisa, Miski Aghnia, et al.
Publicado: (2023)

Exploring the factor structure of the Health of the Nation Outcomes Scale (HoNOS) in a sample of patients with schizophrenia, schizotypal and delusional disorders
por: Smith, Wayne, et al.
Publicado: (2017)

Gross anatomical features of the insular cortex in schizophrenia and schizotypal personality disorder: Potential relationships with vulnerability, illness stages, and clinical subtypes
por: Takahashi, Tsutomu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ust2hemhkk3gkv8b84ehb81anl